Search Results - "van Gelder, I C"

External validation and updating of prediction models of bleeding risk in patients with cancer receiving anticoagulants by Trinks-Roerdink, EM, Geersing, GJ, Hemels, MEW, van Gelder, IC, Klok, FA, van Smeden, M, Rutten, FH, van Doorn, S

“…ObjectivePatients with cancer are at increased bleeding risk, and anticoagulants increase this risk even more. Yet, validated bleeding risk models for…”
Get full text

The cost of illness of atrial fibrillation: a systematic review of the recent literature by Wolowacz, S.E., Samuel, M., Brennan, V.K., Jasso-Mosqueda, J.-G., Van Gelder, I.C.

“…Atrial fibrillation (AF) is the most common cardiac arrhythmia, its prevalence increasing markedly with age. Atrial fibrillation is strongly associated with…”
Get full text

Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure by Crijns, H.J.G.M, Tjeerdsma, G, de Kam, P.J, Boomsma, F, van Gelder, I.C, van den Berg, M.P, van Veldhuisen, D.J

“…Aims To examine whether the presence, or development, of atrial fibrillation in patients with advanced chronic heart failure, is associated with a poorer…”
Get full text

Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women by Siland, J E, Nguyen, B O, de With, R R, Van Gelder, I C, van der Harst, P, Rienstra, M

“…Limited causal evidence is available on the relationship between body mass index (BMI) and atrial fibrillation (AF) progression. Sex differences have been…”
Get full text

Paradigm shifts in pathophysiology and management of atrial fibrillation—a tale of the RACE trials in the Netherlands by Crijns, H. J. G. M., Van Gelder, I. C.

“…In the past 20 years the Netherlands-based RACE trials have investigated important concepts in clinical atrial fibrillation (AF). Their scope ranged from…”
Get full text

Heart rate increase and inappropriate sinus tachycardia after cryoballoon pulmonary vein isolation for atrial fibrillation by van Deutekom, C., Mulder, B. A., Groenveld, H. F., Tieleman, R. G., Wiesfeld, A. C. P., Tan, E. S., van Gelder, I. C., Rienstra, M., Blaauw, Y.

“…Background Cryoballoon pulmonary vein isolation (PVI) is a common therapy for atrial fibrillation (AF). While moderately increased sinus rhythm heart rate (HR)…”
Get full text

QT lengthening and life-threatening arrhythmias associated with fexofenadine by Pinto, YM, van Gelder, IC, Heeringa, M, Crijns, HJGM

“…For clinicians treating patients with suspected or known QTc prolongation and ventricular arrhythmias, it is important to be aware of rare but life-threatening…”
Get full text

Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST) by te Rijdt, W. P., Hoorntje, E. T., de Brouwer, R., Oomen, A., Amin, A., van der Heijden, J. F., Karper, J. C., Westenbrink, B. D., Silljé, H. H. W., te Riele, A. S. J. M., Wiesfeld, A. C. P., van Gelder, I. C., Willems, T. P., van der Zwaag, P. A., van Tintelen, J. P., Hillege, J. H., Tan, H. L., van Veldhuisen, D. J., Asselbergs, F. W., de Boer, R. A., Wilde, A. A. M., van den Berg, M. P.

“…Background The p.Arg14del (c.40_42delAGA) phospholamban (PLN) pathogenic variant is a founder mutation that causes dilated cardiomyopathy (DCM) and…”
Get full text

PREVENTION-ACHD: PRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease; Rationale and Design by Vehmeijer, J. T., Koyak, Z., Zwinderman, A. H., Harris, L., Peinado, R., Oechslin, E. N., Silversides, C. K., Bouma, B. J., Budts, W., van Gelder, I. C., Oliver, J. M., Mulder, B. J. M., de Groot, J. R.

“…Background Many adult congenital heart disease (ACHD) patients are at risk of sudden cardiac death (SCD). An implantable cardioverter-defibrillator (ICD) may…”
Get full text

Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation by Al-Jazairi, M. I. H., Rienstra, M., Klinkenberg, T. J., Mariani, M. A., Van Gelder, I. C., Blaauw, Y.

“…Background Combined ‘hybrid’ thoracoscopic and percutaneous atrial fibrillation (AF) ablation is a strategy used to treat AF in patients with therapy-resistant…”
Get full text

Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system by van den Berg, M.P, Hassink, R.J, Tuinenburg, A.E, van Sonderen, E.F.L.P, Lefrandt, J.D, de Kam, P.J, van Gelder, I.C, Smit, A.J, Sanderman, R, Crijns, H.J.G.M

“…Aims To determine the impact of paroxysmal atrial fibrillation on quality of life and to determine the predictors of quality of life, particularly the role of…”
Get full text

Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy by van der Zwaag, P. A., van Rijsingen, I. A. W., de Ruiter, R., Nannenberg, E. A., Groeneweg, J. A., Post, J. G., Hauer, R. N. W., van Gelder, I. C., van den Berg, M. P., van der Harst, P., Wilde, A. A. M., van Tintelen, J. P.

“…Background Recently, we showed that the c.40_42delAGA (p.Arg14del) mutation in the phospholamban (PLN) gene can be identified in 10–15 % of Dutch patients with…”
Get full text

Stroke risk in patients with device-detected atrial high-rate episodes by Erküner, Ö., Rienstra, M., Van Gelder, I. C., Schotten, U., Crijns, H. J. G. M., Luermans, J. G. L. M.

“…Cardiovascular implantable electronic devices (CIEDs) can detect atrial arrhythmias, i. e. atrial high-rate episodes (AHRE). The thrombo-embolic risk in…”
Get full text

Non vitamin K anticoagulation drugs will win the race by Van Gelder, I. C., De With, R. R., Rienstra, M.

“…An analysis of the first 10,000 patients from the GLObal RegIstry on long-term oral Anti-thrombotic treatment in patients with Atrial Fibrillation (GLORIA-AF)…”
Get full text

Heart failure and atrial fibrillation: current concepts and controversies by Van den Berg, M. P., Tuinenburg, A. E., Crijns, H. J., Van Gelder, I. C., Gosselink, A. T., Lie, K. I.

“…Heart failure and atrial fibrillation are very common, particularly in the elderly. Owing to common risk factors both disorders are often present in the same…”
Get full text

Treatment of atrial fibrillation by Blaauw, Y, Van Gelder, I C, Crijns, H J G M

“…Antiarrhythmic drugs may cause ventricular proarrhythmia, conduction disturbances, and heart failure. [...]these patients should be informed about the symptoms…”
Get full text

Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants by Spronk, Henri M H, de Jong, Anne Margreet, Crijns, Harry J, Schotten, Ulrich, Van Gelder, Isabelle C, Ten Cate, Hugo

“…Factor Xa and thrombin are well-known components of the coagulation cascade and have been proven to be viable targets for effective anticoagulation treatment…”
Get full text

Early Recurrences of Atrial Fibrillation After Electrical Cardioversion: A Result of Fibrillation-Induced Electrical Remodeling of the Atria? by Tieleman, Robert G, Van Gelder, Isabelle C, Crijns, Harry J.G.M, De Kam, Pieter J, Van Den Berg, Maarten P, Haaksma, Jaap, Van Der Woude, Hanneke J, Allessie, Maurits A

“…Objectives. We sought to investigate whether, in humans, the timing and incidence of a relapse of atrial fibrillation (AF) during the first month after…”
Get full text

Paroxysmal atrial fibrillation, quality of life and neuroticism by VAN DEN BERG, M. P, RANCHOR, A. V, VAN SONDEREN, F. L. P, VAN GELDER, I. C, VAN VELDHUISEN, D. J

“…Paroxysmal atrial fibrillation (AF) is associated with significant impairment of quality of life (QoL), which is to a large extent independent of objective…”
Get full text

Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation by De Jong, Anne Margreet, Maass, Alexander H, Oberdorf-Maass, Silke U, Van Veldhuisen, Dirk J, Van Gilst, Wiek H, Van Gelder, Isabelle C

“…Structural remodelling occurring before, due to the underlying heart disease, and during atrial fibrillation (AF) sets the stage for permanent AF. Current…”
Get full text